V.R. Medi Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 33 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.70 M
- Satisfied Charges ₹ 1.00 M
About V.R. Medi Drugs
V.R. Medi Drugs Private Limited (VMDPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 1991 and has a history of 33 years and eight months. Its registered office is in Uttar Pradesh, Uttar Pradesh.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.70 M. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Neetu Agarwal and Shalini Bass serve as directors at the Company.
Company Details
- Location Uttar Pradesh, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231UP1991PTC013228
- Company No.
013228
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 1991
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at V.R. Medi Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neetu Agarwal  | Director | 14-Feb-2015 | Current |
| Shalini Bass | Director | 28-Nov-2022 | Current |
Financial Performance of V.R. Medi Drugs.
V.R. Medi Drugs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of V.R. Medi Drugs?
In 2017, V.R. Medi Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.70 M
₹1.00 M
Charges Breakdown by Lending Institutions
- Others : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2017 | Others | ₹0.70 M | Open |
| 14 May 1992 | Bareilly Corporation Bank Ltd. | ₹0.50 M | Satisfied |
| 04 May 1992 | Bank Of Baroda | ₹0.50 M | Satisfied |
How Many Employees Work at V.R. Medi Drugs?
Unlock and access historical data on people associated with V.R. Medi Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of V.R. Medi Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V.R. Medi Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
